Company: OXBRW
Filing Date: 2025-07-10
Form Type: 8-K
Source: 0001641172-25-018541
Chunk: 0

Company: OXBRIDGE RE HOLDINGS Ltd
Filing Date: 2025-07-10
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01 Entry into
a Material Definitive Agreement.

On
July 9, 2025, Oxbridge Re Holdings Limited (the “ Company”) entered into an Equity Distribution Agreement (the “ Offering
Agreement”) with Maxim Group LLC, as sales agent (the “ Sales Agent”), pursuant to which the Company could offer and
sell, from time to time, through the Sales Agent up to $5 million of the Company’s ordinary shares, $0.001 par value (“ Ordinary
Shares”). The expiration date of the Offering Agreement is the earlier of (i) the issuance and sale of the Ordinary Shares having
an aggregate offering price equal to $5 million, or (ii) the termination of the Offering Agreement by either the Sales Agent or the Company,
in each such party’s sole discretion, upon the provision of thirty (30) days’ written notice. The Company will pay the Sales
Agent a commission equal to 3.0% of the gross proceeds of the Ordinary Shares sold by the Sales Agent pursuant to the Offering Agreement.
The Sales Agreement replaced our prior sales agreement dated September 30, 2022 with the Sales Agent pursuant to which the Company sold
Ordinary Shares having an aggregate sales price of $4.6 million.

Sales
of the Ordinary Shares under the Offering Agreement, if any, may be made in transactions that are deemed to be “at-the-market”
offerings as defined in Rule 415 under the Securities Act of 1933, as amended, including without limitation sales made directly on or
through the Nasdaq Capital Market or any other existing trading market for the Ordinary Shares. The Sales Agent will use commercially
reasonable efforts consistent with its normal trading and sales practices to sell the Ordinary Shares from time to time, based upon instructions
from the Company (including any price, time or amount limits the Company may impose). The Company is not obligated to make any sales under
the Offering Agreement.

The Company intends to use
the net proceeds from the offering for general corporate purposes, including the funding of the Company’s reinsurance operations.
Pending their use, the Company intends to invest the net proceeds from the offering in short-term, investment grade, interest bearing
instruments or hold them as cash.

Pursuant
to General Instruction I. B.6 of Form S-3, Ordinary Shares having an aggregate offering price of up to $517,745 were registered pursuant
to the Company’s shelf registration statement on Form S-3 (File No. 333-